Thomas John T. - 01 Mar 2024 Form 4 Insider Report for Physicians Realty Trust

Role: President and CEO, Director
Signature: /s/ Christopher M. Bartoli, as attorney-in-fact
Issuer symbol: N/A
Transactions as of: 01 Mar 2024
Net transactions value: -$2,936,084
Form type: 4
Filing time: 01 Mar 2024, 16:13:40 UTC
Previous filing: 22 Jan 2024
Next filing: 30 Apr 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	DOC	Common shares, $0.01 par value	Options Exercise		+259,067	+37%		955,938	01 Mar 2024	Direct	F1
transaction	DOC	Common shares, $0.01 par value	Options Exercise		+244,932	+26%		1,200,870	01 Mar 2024	Direct	F2
transaction	DOC	Common shares, $0.01 par value	Options Exercise		+281,022	+23%		1,481,892	01 Mar 2024	Direct	F3
transaction	DOC	Common shares, $0.01 par value	Tax liability	$2,936,084	-261,450	-18%	$11.23	1,220,442	01 Mar 2024	Direct
transaction	DOC	Common shares, $0.01 par value	Disposed to Issuer		-1,220,442	-100%		0	01 Mar 2024	Direct	F4
transaction	DOC	Common shares, $0.01 par value	Disposed to Issuer		-5,217	-100%		0	01 Mar 2024	Represents shares held by the Reporting Person's child	F4
transaction	DOC	Common shares, $0.01 par value	Disposed to Issuer		-434	-100%		0	01 Mar 2024	Represents shares held by the Reporting Person's child	F4
transaction	DOC	Common shares, $0.01 par value	Disposed to Issuer		-217	-100%		0	01 Mar 2024	Represents shares held by the Reporting Person's child	F4
transaction	DOC	Common shares, $0.01 par value	Disposed to Issuer		-217	-100%		0	01 Mar 2024	Represents shares held by the Reporting Person's child	F4
transaction	DOC	Common shares, $0.01 par value	Disposed to Issuer		-87	-100%		0	01 Mar 2024	Represents shares held by the Reporting Person's child	F4
transaction	DOC	Common shares, $0.01 par value	Disposed to Issuer		-87	-100%		0	01 Mar 2024	Represents shares held by the Reporting Person's child	F4
transaction	DOC	Common shares, $0.01 par value	Disposed to Issuer		-87	-100%		0	01 Mar 2024	Represents shares held by the Reporting Person's child	F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	DOC	2020 Restricted Share Unit Grant	Options Exercise	$0	-259,067	-100%	$0.000000^*	0	01 Mar 2024	Common shares, $0.01 par value	259,067		Direct	F5
transaction	DOC	2022 Performance Based Restricted Share Unit Grant	Options Exercise	$0	-81,644	-100%	$0.000000^*	0	01 Mar 2024	Common shares, $0.01 par value	81,644		Direct	F6
transaction	DOC	2023 Performance Based Restricted Share Unit Grant	Options Exercise	$0	-93,674	-100%	$0.000000^*	0	01 Mar 2024	Common shares, $0.01 par value	93,674		Direct	F7

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Thomas John T. is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id	Content
F1	Each restricted stock unit represents the right to receive one share of the Issuer's common shares. Represents vesting of the time-based restricted stock units on March 1, 2024 pursuant to the terms of the Agreement and Plan of Merger (the "Merger Agreement") dated October 29, 2023 among the Issuer, Physicians Realty L.P., Healthpeak Properties, Inc. ("Healthpeak"), DOC DR Holdco, LLC and DOC DR LLC. The Issuer merged with and into DOC DR Holdco, LLC on March 1, 2024.
F2	Represents vesting of the 2022 Performance Based Restricted Share Units granted on March 1, 2022 under the Issuer's Equity Incentive Plan (the "Plan"). The grant vested on March 1, 2024 pursuant to the terms of the Merger Agreement dated October 29, 2023 among the Issuer, Physicians Realty L.P., Healthpeak, DOC DR Holdco, LLC and DOC DR LLC. Pursuant to the terms of the Merger Agreement, the Reporting Person received 244,932 common shares upon vesting, 300% of the target shares.
F3	Represents vesting of the 2023 Performance Based Restricted Share Units granted on March 1, 2023 under the the Plan. Pursuant to the terms of the Merger Agreement, the Reporting Person received 281,022 common shares upon vesting, 300% of the target shares.
F4	Represents securities disposed of pursuant to the terms of the the Merger Agreement and each issued and outstanding common shares of the Issuer, held by the reporting person was automatically converted into the right to receive 0.674 of a share of Healthpeak common stock, subject to any adjustment, without interest.
F5	On March 2, 2020, the Reporting Person was granted 259,067 restricted stock units, expected to vest in two equal installments on March 2, 2024 and March 2, 2025, subject to the terms of the grant. The grant vested on March 1, 2024 pursuant to the terms of the Merger Agreement.
F6	On March 1, 2022, the Reporting Person was granted 81,644 performance share units under the Issuer's Plan, which represent the "target" number of shares underlying the performance share units. Pursuant to the terms of the merger, the Reporting Person received 244,932 common shares upon vesting.
F7	On March 1, 2023, the Reporting Person was granted 93,674 performance share units under the Issuer's Plan, which represent the "target" number of shares underlying the performance share units. Pursuant to the terms of the merger, the Reporting Person received 281,022 common shares upon vesting.